Invivyd (IVVD) Cash from Investing Activities (2021 - 2025)

Invivyd's (IVVD) quarterly Cash from Investing Activities came in at -$11000.0 in Q2 2025, up 92.36% on a QoQ basis from -$144000.0 in Q1 2025.

Invivyd (IVVD) Cash from Investing Activities (2021 - 2025) Analysis & Trends

Invivyd (IVVD) has 5 years of Cash from Investing Activities data on file, last reported at -$11000.0 in Q2 2025.

Quarterly Cash from Investing Activities changed N/A year-over-year to -$11000.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was -$155000.0 (down 10.71% YoY) and the FY2025 annual result came in at -$155000.0, down 10.71% from the prior year.
Cash from Investing Activities climbed to -$11000.0 in Q2 2025, from -$144000.0 in the prior quarter.
In the past five years, Cash from Investing Activities ranged from a high of $137.9 million in Q4 2021 to a low of -$188.6 million in Q3 2021.
A 5-year average of -$65933.3 and a median of -$5000.0 in 2024 frame the typical range for Cash from Investing Activities.
Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 200.65% — and 2023, when it soared 191835.29%.
Tracing IVVD's Cash from Investing Activities over 5 years: stood at $137.9 million in 2021, then slumped by 200.65% to -$138.8 million in 2022, then surged by 156.13% to $77.9 million in 2023, then plunged by 99.99% to $5000.0 in 2024, then sank by 320.0% to -$11000.0 in 2025.
The last three Cash from Investing Activities figures came in at -$11000.0 (Q2 2025), -$144000.0 (Q1 2025), and $5000.0 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Activities (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-45.80 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-92.70 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-1.66 Bn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-49.35 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	19.77 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-229.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-363.46 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	24.51 Mn
10	Invivyd	212.23 Mn	52.15 Mn	13.01 Mn	-

Download Data